{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:11:23Z","timestamp":1790028683389,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["R35CA197725"],"award-info":[{"award-number":["R35CA197725"]}]},{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"crossref","award":["81571803"],"award-info":[{"award-number":["81571803"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010871","name":"Thousand Talents Plan","doi-asserted-by":"crossref","award":["2017-01-07-00-07-E00038"],"award-info":[{"award-number":["2017-01-07-00-07-E00038"]}],"id":[{"id":"10.13039\/501100010871","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Science and International Cooperation Program","award":["16410724300"],"award-info":[{"award-number":["16410724300"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.nano.2018.11.015","type":"journal-article","created":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T04:47:58Z","timestamp":1544676478000},"page":"126-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Repolarization of myeloid derived suppressor cells via magnetic nanoparticles to promote radiotherapy for glioma treatment"],"prefix":"10.1016","volume":"16","author":[{"given":"Congyu","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Muroski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Miska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Lee-Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Lopez-Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej S.","family":"Lesniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2018.11.015_bb0005","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3389\/fneur.2017.00748","article-title":"Advances in radiotherapy for glioblastoma","volume":"8","author":"Mann","year":"2017","journal-title":"Front Neurol"},{"key":"10.1016\/j.nano.2018.11.015_bb0010","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM198012043032303","article-title":"Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery","volume":"303","author":"Walker","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2018.11.015_bb0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clon.2016.09.015","article-title":"Radiotherapy in glioblastoma: the past, the present and the future","volume":"29","author":"Gzell","year":"2017","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.nano.2018.11.015_bb0020","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.30.9.907","article-title":"Assumptions in the radiotherapy of glioblastoma","volume":"30","author":"Hochberg","year":"1980","journal-title":"Neurology"},{"key":"10.1016\/j.nano.2018.11.015_bb0025","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJMoa065901","article-title":"Radiotherapy for glioblastoma in the elderly","volume":"356","author":"Keime-Guibert","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2018.11.015_bb0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.7150\/ijms.3635","article-title":"Cancer and radiation therapy: current advances and future directions","volume":"9","author":"Baskar","year":"2012","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.nano.2018.11.015_bb0035","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2018.11.015_bb0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0090-3019(03)00137-X","article-title":"Radiation-induced gliomas: report of 10 cases and review of the literature","volume":"60","author":"Salvati","year":"2003","journal-title":"Surg Neurol"},{"key":"10.1016\/j.nano.2018.11.015_bb0045","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1259\/0007-1285-22-261-521","article-title":"The influence of energy absorption and electron range on dosage in irradiated bone","volume":"22","author":"Spiers","year":"1949","journal-title":"Br J Radiol"},{"key":"10.1016\/j.nano.2018.11.015_bb0050","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.7150\/thno.22172","article-title":"Metal-based nanoenhancers for future radiotherapy: Radiosensitizing and synergistic effects on tumor cells","volume":"8","author":"Liu","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.nano.2018.11.015_bb0055","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.canlet.2016.03.011","article-title":"Nanoparticles in radiation oncology: from bench-side to bedside","volume":"375","author":"Rancoule","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.nano.2018.11.015_bb0060","doi-asserted-by":"crossref","first-page":"N309","DOI":"10.1088\/0031-9155\/49\/18\/N03","article-title":"The use of gold nanoparticles to enhance radiotherapy in mice","volume":"49","author":"Hainfeld","year":"2004","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.nano.2018.11.015_bb0065","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20140134","article-title":"The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy","volume":"87","author":"Sancey","year":"2014","journal-title":"Brit J Radiol"},{"key":"10.1016\/j.nano.2018.11.015_bb0070","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1088\/0031-9155\/55\/2\/009","article-title":"Enhancement of irradiation effects on cancer cells by cross-linked dextran-coated iron oxide (CLIO) nanoparticles","volume":"55","author":"Huang","year":"2010","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.nano.2018.11.015_bb0075","doi-asserted-by":"crossref","first-page":"23047","DOI":"10.1021\/jp306543q","article-title":"Nanoparticle location and material dependent dose enhancement in X-ray radiation therapy","volume":"116","author":"Hossain","year":"2012","journal-title":"J Phys Chem C Nanomater Interfaces"},{"key":"10.1016\/j.nano.2018.11.015_bb0080","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrclinonc.2016.211","article-title":"Radiotherapy and immunotherapy: a beneficial liaison?","volume":"14","author":"Weichselbaum","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.nano.2018.11.015_bb0085","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1158\/0008-5472.CAN-16-0144","article-title":"CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells","volume":"76","author":"Chang","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.nano.2018.11.015_bb0090","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1172\/JCI80005","article-title":"Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected","volume":"125","author":"Marvel","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nano.2018.11.015_bb0095","doi-asserted-by":"crossref","first-page":"721s","DOI":"10.1158\/1078-0432.CCR-06-2197","article-title":"Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma","volume":"13","author":"Ochoa","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nano.2018.11.015_bb0100","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-05-1299","article-title":"Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host","volume":"66","author":"Huang","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.nano.2018.11.015_bb0105","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1158\/0008-5472.CAN-12-1597","article-title":"Myeloid-derived suppressor cells as a vehicle for tumor-specific oncolytic viral therapy","volume":"73","author":"Eisenstein","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.nano.2018.11.015_bb0110","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ccr.2004.08.031","article-title":"Expansion of myeloid immune suppressor gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis","volume":"6","author":"Yang","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.nano.2018.11.015_bb0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12307-011-0091-6","article-title":"Origin and functions of tumor-associated myeloid cells (TAMCs)","volume":"5","author":"Sica","year":"2012","journal-title":"Cancer Microenviron"},{"key":"10.1016\/j.nano.2018.11.015_bb0120","article-title":"Re-polarizing myeloid-derived suppressor cells (MDSCs) with cationic polymers for cancer immunotherapy","volume":"6","author":"He","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2018.11.015_bb0125","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nnano.2016.168","article-title":"Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues","volume":"11","author":"Zanganeh","year":"2016","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.nano.2018.11.015_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12645-016-0024-7","article-title":"Application of nanotechnology to cancer radiotherapy","volume":"7","author":"Mi","year":"2016","journal-title":"Cancer Nanotechnol"},{"key":"10.1016\/j.nano.2018.11.015_bb0135","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.7150\/thno.11642","article-title":"Nanoparticles for radiation therapy enhancement: the key parameters","volume":"5","author":"Retif","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.nano.2018.11.015_bb0140","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1021\/nl301499u","article-title":"Nanoscale magnetism control via surface and exchange anisotropy for optimized ferrimagnetic hysteresis","volume":"12","author":"Noh","year":"2012","journal-title":"Nano Lett"},{"key":"10.1016\/j.nano.2018.11.015_bb0145","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.7150\/thno.18352","article-title":"Elongated nanoparticle aggregates in cancer cells for mechanical destruction with low frequency rotating magnetic field","volume":"7","author":"Shen","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.nano.2018.11.015_bb0150","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/cbin.10459","article-title":"Effect of the surface modification, size, and shape on cellular uptake of nanoparticles","volume":"39","author":"Salatin","year":"2015","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.nano.2018.11.015_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2018.11.015_bb0160","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.addr.2006.09.013","article-title":"Recent advances in iron oxide nanocrystal technology for medical imaging","volume":"58","author":"Corot","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2018.11.015_bb0165","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1470-2045(14)70021-X","article-title":"Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET\/CT scans for children and young adults with cancer: a prospective, non-randomised, single-Centre study","volume":"15","author":"Klenk","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.nano.2018.11.015_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.nano.2018.11.015_bb0175","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2018.11.015_bb0180","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1021\/nn300291r","article-title":"Dual enzyme-like activities of iron oxide nanoparticles and their implication for diminishing cytotoxicity","volume":"6","author":"Chen","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2018.11.015_bb0185","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.nano.2018.11.015_bb0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7150\/jca.5047","article-title":"Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thieves","volume":"4","author":"Sevko","year":"2013","journal-title":"J Cancer"},{"key":"10.1016\/j.nano.2018.11.015_bb0195","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.nano.2018.11.015_bb0200","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1021\/acsnano.5b06779","article-title":"Bioconjugated manganese dioxide nanoparticles enhance chemotherapy response by priming tumor-associated macrophages toward M1-like phenotype and attenuating tumor hypoxia","volume":"10","author":"Song","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2018.11.015_bb0205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.immuni.2017.12.014","article-title":"Activation of p53 in immature myeloid precursor cells controls differentiation into Ly6c(+)CD103(+) monocytic antigen-presenting cells in tumors","volume":"48","author":"Sharma","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.nano.2018.11.015_bb0210","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1039\/C7CS00657H","article-title":"Construction of iron oxide nanoparticle-based hybrid platforms for tumor imaging and therapy","volume":"47","author":"Hu","year":"2018","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.nano.2018.11.015_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201705673","article-title":"Recent advances in magnetic-nanomaterial-based mechanotransduction for cell fate regulation","volume":"30","author":"Wu","year":"2018","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2018.11.015_bb0220","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1021\/acs.accounts.6b00559","article-title":"Synergism of nanomaterials with physical stimuli for biology and medicine","volume":"50","author":"Shin","year":"2017","journal-title":"Acc Chem Res"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963418305665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963418305665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T21:32:19Z","timestamp":1551735139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963418305665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":44,"alternative-id":["S1549963418305665"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2018.11.015","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repolarization of myeloid derived suppressor cells via magnetic nanoparticles to promote radiotherapy for glioma treatment","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2018.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}